Abstract
We used chemosensitive and chemoresistant variants of the neoplastic mouse MXT mammary and human J82 and T24 bladder cell lines to characterize verapamil-induced cell proliferation and morphonuclear modifications in drug-treated and untreated cells. Chemoresistance to vinorelbine (Navelbine, aVinca alkaloid derivative), to DIAM3 (an investigational alkylating compound) and to Adriamycin (an intercalating agent) in the presence or absence of verapamil was monitored by means of the colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The results showed that verapamil restored a significant level of chemosensitivity in doses such as 1 μM or 10 μM in the three chemoresistant variants. The digital cell image analysis of Feulgen-stained T24-resistant cell nuclei revealed that verapamil restored the drug-treated cell kinetics and morphonuclear features observed in the sensitive counterpart especially with respect to the effects of adriamycin. Interestingly, verapamil induced a highly significant chromatin decondensation in resistant but not in sensitive variants. Such verapamil-induced decondensation may favour the accessibility of drugs to their DNA targets. Therefore, in addition to the well-known action of the drug on the influx of a cytotoxic compound from the cellular to the intracellular compartment, verapamil might also favour the accessibility of the nucleus, to the drug.
Similar content being viewed by others
Abbreviations
- Pgp:
-
P glycoprotein
- MTT:
-
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- R:
-
resistant
- S:
-
sensitive
- A ini :
-
integrated absorbance
References
Akiyama SI, Cornwell MM, Kuwano M, Pastan I, Gottesman MM (1988) Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. Mol Pharmacol 33:144–147
Bartels PH (1983) Numerical evaluation of cytologic data. Bivariate distributions and Bayesian decision boundary. Anal Quant Cytol Histol 2:77–83
Beck WT (1990) Mechanisms of multidrug resistance in human tumor cells. The role of P-glycoprotein, DNA topoisomerase II and other factors. Cancer Treat Rev 17 [Suppl A]:11–20
Bellamy WT, Dalton WS, Kailey JM, Gleason MC, McCloskey TM, Dorr RT, Alberts DS (1988) Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage. Cancer Res 48:6303–6308
Bhalla K, Hindenburg A, Taub RN, Grant S (1985) Isolation and characterization of an anthracycline-resistant human leukemic cell line. Cancer Res 45:3657–3662
Bhuyan BK, Smith KS, Kelly RC, Adams EG, Abraham I, Sampson KE (1993) Multidrug resistance is a component of V79 cell resistance to the alkylating agent adozelesin. Cancer Res 53:1354–1359
Brugal G, Garbay C, Giroud F, Adhel D (1979) A double scanning microphotometer for image analysis: hardware, software and biomedical applications. J Histochem Cytochem 27:144–152
Bubenik J, Baresova J, Jakoubkova J, Sainerova H, Donner J (1973) Etablished cell line of urinary bladder carcinoma (T24) containing tumour-sspecific antigen. Int J Cancer 11:765–773
Carmichael C, De Graff WG, Gazdar AF, Minna D, Mitchell B (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47:936–942
Chauffert B, Martin F, Caignard A, Jeannin JF, Lecler A (1984) Cytofluorescence localization of Adriamycin in resistant colon cancer cells. Cancer Chemother Pharmacol 13:14–18
Colomb E, Dussert C, Martin PM (1991) Nuclear texture parameters as discriminant factors in cell cycle effect and drug sensitivity studies. Cytometry 12:119–126
Dufer J, Akeli MG, Jeannesson P, Desplaces A, Jardillier JC (1989) Quantitative morphological analysis of Adriamycin resistant human K562 leukemic cells. Cytometry 10:37–43
Etiévant C, Kruczynski A, Pauwels O, Kiss R (1991) The combination of the tetrazolium derivative reduction (MTT) and digital cell image analysis to monitor in vitro the cytotoxicity of anti-neoplastic drugs. Anticancer Res 11:305–312.
Ford JM, Hait WN (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42:155–199
Foxwell BMJ, Mackie A, Ling V, Ryffel B (1989) Identification of the multidrug resistance related P-glycoprotein as a cyclosporine binding protein. Mol Pharmacol 36:543–546
Galloway MM (1975) Texture analysis using gray run lengths. Comput Graph Image Proc 4:172–179
Giavazzi R, Scholar E, Hart IR (1982) Isolation and preliminary characterization of an Adriamycin-resistant murine fibrosarcoma cell line. Cancer Res 43:2216–2222
Haralick RM, Shanmugam T, Dinstein I (1973) Textural features for image classification. IEE Trans Syst Man Cybern SMC 3:610–620
Hunter T, Karin M (1972) The regulation of transcription by phosphorylation. Cell 70:375–387
Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in chinese hamster ovary cell mutants. Biochem Biophys Acta 455:152–162
Kalken CK van, Pinedo HM, Giaccone G (1991) Multidrug resistance from the clinical point of view. Eur J Cancer 27:1481–1486
Kaye SB (1990) Reversal of multidrug resistance. Cancer Treat Rev 17:37–43
Keizer HG, Schuurhuis GJ, Broxterman HJ, Lankelma J, Schoonen WGEJ, Rijn J van, Pinedo HM, Joenje H (1989) Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells. Cancer Res 49:2988–2993
Kiss R, Devleeschouwer N, Paridaens R, Danguy A, Atassi G (1986) Phenotypic change of the transplantable MXT mammary adenocarcinoma into mixed bone producing sarcoma-like tumors. Anticancer Res 6:753–760
Kiss R, Launoit Y de, Danguy A, Paridaens R, Pasteels JL (1989) Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors. Cancer Res 49:2945–2951
Klohs W, Steinkampf RW (1988) Possible link between the intrinsic drug resistance of colon tumors and a detoxification mechanism of intestinal cells. Cancer Res 48:3025–3030
Kramer RA, Zaher J, Kim G (1988) Role of the glutathione redox cycle in acquired and de novo multidrug resistance. Science 241:694–697
Labarre JF (1985) Natural polyamines linked cyclophosphazenes. Attempts as the production of more selective antitumorals. Topic Curr Chem 129:173–260
Launoit Y de, Kiss R (1989) In vivo influence of androgens on the cell kinetics and chromatin pattern of the MXT mouse mammary tumor treated or not by aminogluthetimide. J Cancer Res Clin Oncol 115:129–138
Launoit Y de, Kiss R, Danguy A (1990) Influence of smear preparation and fixatives on the DNA ploidy and the morphonuclear features of the MXT mammary tumor and normal tissues in the mouse. Cytometry 11:691–699
Marquardt D, Center MS (1992) Drug transport mechanisms in HL60cells isolated for resistance to Adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells. Cancer Res 52:3157–3163
Mosman T (1983) Rapid colorimetric assay for cellular growth and survival application and cytotoxicity assay. J Immunol Methods 65:55–63
O'Toole C, Price ZH, Ohnuki Y, Unsgaard B (1978) Ultrastructure, kariology and immunology of a cell line originated from a cell line originated from a human transitional-cell carcinoma. Br J Cancer 38:64–76
Pastan I, Gottesman MM (1991) Multidrug resistance. Annu Rev Med 42:277–286
Pauwels I, Kiss R (1991) Digital morphonuclear analyses of sensitive versus resistant neoplastic cells to vinca-alkaloid, alkylating, and intercalating drugs. Cytometry 12:388–397
Pauwels O, Kiss R (1993) Monitoring of chemotherapy-induced morphonuclear modifications by means of digital cell image analysis. J Cancer Res Clin Oncol 119:533–540
Pommier Y, Swartz RE, Zwelling LA, Kettigan D, Mattern MR, Charcosset JY, Jacquemin-Sablon A, Kohn KW (1986) Reduced formation of protein-associated DNA strand breaks in chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res 46:611–616
Rao PN (1980) The molecular basis of drug induced G2 arrest in mammalian cells. Mol Cell Biochem 29:47–57
Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, Heijningen THM van, Kalken CK van, Slovak MJ, De Vries EGE, Valk P van der, Meijer CJLM, Pinedo HM (1993) Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 53:1475–1479
Schuurhuis GS, Broxterman HJ, Cervantes A, Heijningen THM van, Lange JHM de, Baak JPA, Pinedo HM, Lankelma J (1989) Quantitative determination of factors contributing to doxorubicin resistance in multidrug-resistance cells. J Natl Cancer Inst 81:1887–1892
Siegfried JM, Tritton TR, Sartorelli AC (1983) Comparison of anthracycline concentrations in S180 cell lines of varying sensitivity. Eur J Cancer Clin Oncol 19:1133–1141
Tew KD, Clapper ML (1987) Glutathione S-transferase and anticancer drug resistance. In: Wooley PV, Tew KD (eds) Mechanisms of drug resistance in neoplasmic cells. Academic Press, Orlando, pp 141–157
Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967–1972
Waring J (1981) DNA modification and cancer. Annu Rev Biochem 50:159–192
Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM, Pastan I (1986) Single cell analysis of daunomycin uptake and efflux in multidrug resistant and sensitive KB cells: effects of verapamil and other drugs. Cancer Res 46:5941–5946
Yalowich JC, Ross WE (1984) Potentiation of etoposide induced DNA damage by calcium antagonists in L1210 cells in vitro. Cancer Res 44:3360–3365
Author information
Authors and Affiliations
Additional information
Holder of a grant from the Fonds National de la Recherche Scientifique (FNRS, Belgium)
Research Associate with the FNRS, Belgium
Rights and permissions
About this article
Cite this article
Etiévant, C., Pauwels, O. & Kiss, R. Digital cell image analysis of verapamil-induced effects in chemosensitive and chemoresistant neoplastic cell lines. J Cancer Res Clin Oncol 120, 76–84 (1993). https://doi.org/10.1007/BF01200728
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01200728